$36.8m raise, page-14

They have upped the anti, and I love it. ODD in both Europe and the USA. A PRV in the USA. A good safety record from the previous trial.
Against competitor drugs that are having a hard time showing they can work, and that have some safrty issues.

Bring it. Lets get the approval announced. Lets get the finance in the bank. And lets get these trials (EMA first and then FDA) started.

World wide revenue, protected by ODD coming to ANP only. Share holders get dividends, as the company self finances growth through and expanding pipeline.

Hoo Roo $160 million market cap.